Combined Use of Magnesium Sulfate and Fingolimod for Antenatal Neuroprotection against Inflammation-Mediated Experimental Preterm Brain Injury in a Rat Model

References

• March of Dimes, PMNCH, Save the Children, WHO. Born too soon: the global action report on preterm birth. CP Howson, MV Kinney, and JE Lawn (Eds.). Geneva: World Health Organization, 2012.
   Google Scholar
• Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, Adler A, Vera Garcia C, Rohde S, Say L, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379(9832):2162–72. doi:10.1016/S0140-6736(12)60820-4.
   PubMed Web of Science ®Google Scholar
• Kemp MW. Preterm birth, intrauterine infection, and fetal inflammation. Front Immunol. 2014;5:574. doi:10.3389/fimmu.2014.00574.
   PubMed Web of Science ®Google Scholar
• Faro J, Romero R, Schwenkel G, Garcia-Flores V, Arenas-Hernandez M, Leng Y, Xu Y, Miller D, Hassan SS, Gomez-Lopez N. Intra-amniotic inflammation induces preterm birth by activating the NLRP3 inflammasome. Biol Reprod. 2019;100(5):1290–305. doi:10.1093/biolre/ioy261.
   PubMed Web of Science ®Google Scholar
• Romero R, Miranda J, Chaiworapongsa T, Korzeniewski SJ, Chaemsaithong P, Gotsch F, Dong Z, Ahmed AI, Yoon BH, Hassan SS, et al. Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Reprod Immunol. 2014;72(5):458–74. doi:10.1111/aji.12296.
   PubMed Web of Science ®Google Scholar
• Wirbelauer J, Seidenspinner S, Thomas W, Kunzmann S, Speer CP. Funisitis is associated with increased interleukin-10 gene expression in cord blood mononuclear cells in preterm infants ≤32 weeks of gestation. Eur J Obstet Gynecol Reprod Biol. 2011;155(1):31–5. doi:10.1016/j.ejogrb.2010.11.013.
   PubMed Web of Science ®Google Scholar
• Lu H, Huang W, Chen X, Wang Q, Zhang Q, Chang M. Relationship between premature brain injury and multiple biomarkers in cord blood and amniotic fluid. J Matern Fetal Neonatal Med. 2018;31(21):2898–904. doi:10.1080/14767058.2017.1359532.
   PubMed Web of Science ®Google Scholar
• Yavuz A, Sezik M, Ozmen O, Asci H. Fingolimod against endotoxin-induced fetal brain injury in a rat model. J Obstet Gynaecol Res. 2017;43(11):1708–13. Epub 2017 Aug 17. doi:10.1111/jog.13444.
   PubMed Web of Science ®Google Scholar
• Garcia-Flores V, Romero R, Miller D, Xu Y, Done B, Veerapaneni C, Leng Y, Arenas-Hernandez M, Khan N, Panaitescu B, et al. Inflammation-induced adverse pregnancy and neonatal outcomes can be improved by the immunomodulatory peptide exendin-4. Front Immunol. 2018;9:1291. doi:10.3389/fimmu.2018.01291. eCollection 2018.
   PubMed Web of Science ®Google Scholar
• Dell’Ovo V, Rosenzweig J, Burd I, Merabova N, Darbinian N, Goetzl L. An animal model for chorioamnionitis at term. Am J Obstet Gynecol. 2015;213(3):387.e1–387.10. doi:10.1016/j.ajog.2015.05.007.
   Web of Science ®Google Scholar
• Khatri BO. Fingolimod in the treatment of relapsing-remitting multiple sclerosis: long-term experience and an update on the clinical evidence. Ther Adv Neurol Disord. 2016;9(2):130–47. doi:10.1177/1756285616628766.
   PubMed Web of Science ®Google Scholar
• Zhao P, Yang X, Yang L, Li M, Wood K, Liu Q, Zhu X. Neuroprotective effects of fingolimod in mouse models of Parkinson’s disease. FASEB J. 2017;31(1):172–9. doi:10.1096/fj.201600751R.
   PubMed Web of Science ®Google Scholar
• Aytan N, Choi JK, Carreras I, Brinkmann V, Kowall NW, Jenkins BG, Dedeoglu A. Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer’s disease. Sci Rep. 2016;6:24939. doi:10.1038/srep24939.
   PubMed Web of Science ®Google Scholar
• Wei Y, Yemisci M, Kim HH, Yung LM, Shin HK, Hwang SK, Guo S, Qin T, Alsharif N, Brinkmann V, et al. Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann Neurol. 2011;69(1):119–29. doi:10.1002/ana.22186.
   PubMed Web of Science ®Google Scholar
• Serdar M, Herz J, Kempe K, Lumpe K, Reinboth BS, Sizonenko SV, Hou X, Herrmann R, Hadamitzky M, Heumann R, et al. Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia. Brain Behav Immun. 2016;52:106–19. doi:10.1016/j.bbi.2015.10.004.
   PubMed Web of Science ®Google Scholar
• Khatri BO, Pelletier J, Kappos L, Hartung HP, Comi G, Barkhof F, von Rosenstiel P, Meng X, Grinspan A, Hashmonay R, et al. Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS). Mult Scler Relat Disord. 2014;3(3):355–63. doi:10.1016/j.msard.2013.11.006.
   PubMed Web of Science ®Google Scholar
• Karlsson G, Francis G, Koren G, Heining P, Zhang X, Cohen JA, Kappos L, Collins W. Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis. Neurology. 2014;82(8):674–80. doi:10.1212/WNL.0000000000000137.
   PubMed Web of Science ®Google Scholar
• Geissbuhler Y, Hortonada EP, Hashmonay R, Randhawa S, editors. Study design of a multinational Gilenya (fingolimod) pregnancy exposure registry. In: The 27th annual meeting of the CMSC and the 5th cooperative meeting of the CMSC-ACTRIMS, Orlando, 2013.
   Google Scholar
• Costantine MM, Drever N. Antenatal exposure to magnesium sulfate and neuroprotection in preterm infants. Obstet Gynecol Clin North Am. 2011;38(2):351–66. doi:10.1016/j.ogc.2011.02.019.
   PubMed Web of Science ®Google Scholar
• Crowther CA, Hiller JE, Doyle LW, Haslam RR. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA. 2003;290(20):2669–76. doi:10.1001/jama.290.20.2669.
   PubMed Web of Science ®Google Scholar
• Rouse DJ, Hirtz DG, Thom E, Varner MW, Spong CY, Mercer BM, Iams JD, Wapner RJ, Sorokin Y, Alexander JM, Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network, et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med. 2008;359(9):895–905. doi:10.1001/jama.290.20.2669.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists Committee on Obstetric Practice; Society for Maternal-Fetal Medicine Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection. Obstet Gynecol. 2010;115:669–71. doi:10.1097/AOG.0b013e3181d4ffa5.
   PubMedGoogle Scholar
• Cho GJ, Hong HR, Hong SC, Oh MJ, Kim HJ. The neuroprotective effect of magnesium sulfate in preterm fetal mice. J Perinat Med. 2015;43(5):537–43. doi:10.1515/jpm-2014-0176.
   PubMed Web of Science ®Google Scholar
• Tam Tam HB, Dowling O, Xue X, Lewis D, Rochelson B, Metz CN. Magnesium sulfate ameliorates maternal and fetal inflammation in a rat model of maternal infection. Am J Obstet Gynecol. 2011;204(4):364.e1–364.e8. doi:10.1016/j.ajog.2010.11.006.
   Web of Science ®Google Scholar
• Dowling O, Chatterjee PK, Gupta M, Tam Tam HB, Xue X, Lewis D, Rochelson B, Metz CN. Magnesium sulfate reduces bacterial LPS-induced inflammation at the maternal-fetal interface. Placenta. 2012;33(5):392–8. doi:10.1016/j.placenta.2012.01.013.
   PubMed Web of Science ®Google Scholar
• Bel Fv, Groenendaal F. Drugs for neuroprotection after birth asphyxia: pharmacologic adjuncts to hypothermia. Semin Perinatol. 2016;40(3):152–9. doi:10.1053/j.semperi.2015.12.003.
   PubMed Web of Science ®Google Scholar
• Cilio MR, Ferriero DM. Synergistic neuroprotective therapies with hypothermia. Semin Fetal Neonatal Med. 2010;15(5):293–8. doi:10.1016/j.siny.2010.02.002.
   PubMed Web of Science ®Google Scholar
• Robertson NJ, Faulkner S, Fleiss B, Bainbridge A, Andorka C, Price D, Powell E, Lecky-Thompson L, Thei L, Chandrasekaran M, et al. Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model. Brain. 2013;136(Pt 1):90–105. doi:10.1093/brain/aws285.
   PubMed Web of Science ®Google Scholar
• Buonocore G, Perrone S, Turrisi G, Kramer BW, Balduini W. New pharmacological approaches in infants with hypoxic-ischemic encephalopathy. Curr Pharm Des. 2012;18(21):3086–100. doi:10.2174/1381612811209023086.
   PubMed Web of Science ®Google Scholar
• Cetinkaya M, Alkan T, Ozyener F, Kafa IM, Kurt MA, Koksal N. Possible neuroprotective effects of magnesium sulfate and melatonin as both pre- and post-treatment in a neonatal hypoxic-ischemic rat model. Neonatology. 2011;99(4):302–10. doi:10.1159/000320643.
   PubMed Web of Science ®Google Scholar
• Di Renzo GC, Mignosa M, Gerli S, Burnelli L, Luzi G, Clerici G, Taddei F, Marinelli D, Bragetti P, Mezzetti D, et al. The combined maternal administration of magnesium sulfate and aminophylline reduces intraventricular hemorrhage in very preterm neonates. Am J Obstet Gynecol. 2005;192(2):433–8. doi:10.1016/j.ajog.2004.07.078.
   PubMed Web of Science ®Google Scholar
• Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, Brozzi F, Tubaro C, Giambanco I. S100B’s double life: intracellular regulator and extracellular signal. Biochim Biophys Acta. 2009;1793(6):1008–22. doi:10.1016/j.bbamcr.2008.11.009.
   PubMed Web of Science ®Google Scholar
• Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 2012;8(9):1254–66. doi:10.7150/ijbs.4679.
   PubMed Web of Science ®Google Scholar
• Sharma R, Leung WL, Zamani A, O’Brien TJ, Casillas Espinosa PM, Semple BD. Neuroinflammation in post-traumatic epilepsy: pathophysiology and tractable therapeutic targets. Brain Sci. 2019;9(11):318. doi:10.3390/brainsci9110318.
   Web of Science ®Google Scholar